AE-941, a standardized shark cartilage, does not improve lung cancer survival

The anti-cancer drug AE-941, a shark cartilage derivative, did not improve overall survival in patients with inoperable stage III non-small cell lung cancer, according to a study published online May 26 in the Journal of the National Cancer Institute.

Read the whole article on Physorg

More from Physorg